• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Allergan (Costa Rica) Natrelle TE Smooth 133S-MX-15-T; expander, skin, inflatable

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Allergan (Costa Rica) Natrelle TE Smooth 133S-MX-15-T; expander, skin, inflatable Back to Search Results
Catalog Number 133S-MX-15-T
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/07/2026
Type of Reportable Event Serious Injury
Event or Problem Description
Healthcare professional reported through sales representative "several holes in it".This record is for the right side.Device was explanted.
 
Event or Problem Description
Healthcare professional reported through sales representative "several holes in it".This record is for the right side.Device was explanted.
 
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The reason for reoperation: deflation.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: d9, h3, h6.Lab results: per the investigation procedure, the device is analyzed through visual inspection microscopic inspection if openings are observed and a weight verification.Per the analysis performed, the assessments of the complaints and any potential manufacturing issue are displayed along with any further actions required: deflation: observed an opening through microscopic inspection assessed as surgical damage.No further actions are required as it is not related to the manufacturing process.None of the other observations performed during the device analysis creases, broken, opening and delamination of the suture tabs are found to be potentially related to the manufacturing process, and, therefore, no further actions are required for these observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Natrelle TE Smooth 133S-MX-15-T
Common Device Name
expander, skin, inflatable
Manufacturer (Section D)
Allergan (Costa Rica)
900 parkway global park
zona franca
la aurora de heredia
CS 
Manufacturer (Section G)
Allergan (Costa Rica)
900 parkway global park
zona franca
la aurora de heredia
CS  
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
+1(847)936-6324
MDR Report Key50037813
Report Number9617229-2026-14143
Device Sequence Number21471564
Product Code LCJ
UDI-Device Identifier10888628044210
Combination Product (Y/N)N
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
K182054
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number133S-MX-15-T
Device Lot Number1348278
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer09/03/2026
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 07/07/2026
Supplement Date Received by Manufacturer09/22/2026
Initial Report FDA Received Date07/27/2026
Supplement Report FDA Received Date09/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/20/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age52 YR
Patient SexFemale
-
-